company background image
MLZ logo

MediPharm Labs DB:MLZ Stock Report

Last Price

€0.042

Market Cap

€18.4m

7D

1.0%

1Y

20.1%

Updated

24 Nov, 2024

Data

Company Financials +

MLZ Stock Overview

A pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. More details

MLZ fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance0/6
Financial Health6/6
Dividends0/6

MediPharm Labs Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MediPharm Labs
Historical stock prices
Current Share PriceCA$0.042
52 Week HighCA$0.07
52 Week LowCA$0.035
Beta0.92
11 Month Change-4.93%
3 Month Change-2.75%
1 Year Change20.11%
33 Year Change-71.18%
5 Year Change-98.41%
Change since IPO-97.60%

Recent News & Updates

Recent updates

Shareholder Returns

MLZDE PharmaceuticalsDE Market
7D1.0%-1.2%-0.02%
1Y20.1%-20.1%8.2%

Return vs Industry: MLZ exceeded the German Pharmaceuticals industry which returned -20.1% over the past year.

Return vs Market: MLZ exceeded the German Market which returned 8.2% over the past year.

Price Volatility

Is MLZ's price volatile compared to industry and market?
MLZ volatility
MLZ Average Weekly Movement18.1%
Pharmaceuticals Industry Average Movement6.9%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.9%
10% least volatile stocks in DE Market2.3%

Stable Share Price: MLZ's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: MLZ's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2015166David Pidduckwww.medipharmlabs.com

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis products.

MediPharm Labs Corp. Fundamentals Summary

How do MediPharm Labs's earnings and revenue compare to its market cap?
MLZ fundamental statistics
Market cap€18.36m
Earnings (TTM)-€8.08m
Revenue (TTM)€26.83m

0.7x

P/S Ratio

-2.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MLZ income statement (TTM)
RevenueCA$39.05m
Cost of RevenueCA$25.34m
Gross ProfitCA$13.71m
Other ExpensesCA$25.46m
Earnings-CA$11.75m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.029
Gross Margin35.10%
Net Profit Margin-30.10%
Debt/Equity Ratio1.3%

How did MLZ perform over the long term?

See historical performance and comparison